Volume s1-31, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



A new drug, Endochin, is reported which possesses activity against experimental toxoplasmosis. Of the sulfa derivatives tested, sulfadiazine and Promin proved to have comparable or greater effect on the infection than Endochin. Other drugs selected for their activity against the exoerythrocytic stages of malaria and which proved to be ineffective in toxoplasmosis included a sulfanilanilide (SN 187), a metanilamide (SN 11,437), a naphthoquinone (SN 8557), an 8-amino-quinoline (SN 13,276), a biguanide (SN 12,837), and an acridone (DR 15,575). Treatment combining sulfadiazine and Endochin was no more efficacious than treatment with either drug by itself.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...


Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error